Siegel%2c Dionicio picture.jpg

Dr. Dionicio R. Siegel

Science Advisory Board Member

Dr. Siegel is Associate Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences' at University of California San Diego.

His research group focuses on the development of synthetic routes to natural products that promote regeneration. These synthetic routes provide the basis for subsequent investigations into the modes of action of the select compounds.

In addition, the established synthetic routes provide avenues for the optimization of the natural products’ biological performance through medicinal chemistry. Concurrent with these studies we evaluate the compounds for the ability to promote neuronal regeneration in vivo through the use of injury models in C. elegans and in collaboration with academic and industrial research groups using different animal models of neuronal injury.

Dr. Siegel received a B.A. Chemistry from Reed College, a Ph.D. Chemistry from Harvard University and completed Postdoctoral Studies in Molecular Pharmacology at the Memorial Sloan Kettering Cancer Center.

Dr. Siegel's biography can be found at: UCSD Dio Siegel

American Seed Trade Association

Green & Grow Inc. (GGI) is pleased to announce that its senior leadership team will again be attending the ASTA Corn, Soybean and Sorghum Conference in Chicago.

GGI will be presenting a preview of our latest 2016 independently designed and run field trials utilizing the Agriplier® Technology as a Seed Treatment in Corn, Soybeans, Cotton, Wheat and Canola. These new results will be added to our existing trial data demonstrating the benefits of Agriplier® either as a seed treatment or soil application across multiple crop types.


Green & Grow Inc. (GGI) is pleased to announce that it has obtained its first registered product in Brazil. This marks a milestone in GGI’s efforts to evaluate potential partners in South America. Brazil continues to be a major player in crops where GGI products have performed well.

GGI continues to evaluate other South American markets and pursue registration in those countries.